Delivery Order SPE2DB22D2206-SPE2DB25FJD15
Award Date 7/29/25
Potential Completion Date 8/19/25
Potential Value $14K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $13,963.18 firm fixed price delivery order to AmerisourceBergen Drug Corp for Talvey 40 mg/ml vials, with an ultimate completion date of August 14, 2025. This non-set-aside competitive award was issued on July 24, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's broader pharmaceutical supply relationship with the federal...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. The contract, valued at $20,145.03, is for the delivery of a specific pharmaceutical product, "TALVEY 40 MG/ML VIALML," and has a completion date of June 11, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $13,963.18, is for the delivery of TALVEY 40 MG/ML VIALML medical supplies. The contract is a firm fixed-price delivery order with a completion date of July 9, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- AmerisourceBergen Drug Corp was awarded a $2,462.36 delivery order by the Defense Logistics Agency (DLA) on July 30, 2025, for the supply of Terlivaz 0.85 mg vials, with a completion date of August 20, 2025. This is a firm fixed price, non-set-aside contract with performance at the company's Conshohocken, Pennsylvania facility. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which carries a...
- The Defense Logistics Agency awarded a delivery order valued at $22,892.70 to AmerisourceBergen Drug Corp for the supply of Tadliq 20 mg/5 ml suspension (150 ml) on August 4, 2025, with an ultimate completion date of August 5, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The place of performance is Conshohocken, Pennsylvania, where AmerisourceBergen's Corporate Office is headquartered. This delivery order is a child contract issued under...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $7,387.08 for Terlivaz 0.85 mg vials on July 24, 2025, with completion targeted for August 14, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $33,955.20 to AmerisourceBergen Drug Corp on July 25, 2025, with an ultimate completion date of July 28, 2025. This firm fixed-price delivery order, which carries no set-aside designation, is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.99 million and extending through December 2026. The place of performance is...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $22,443.00 to AmerisourceBergen Drug Corp on July 26, 2025, with an ultimate completion date of July 28, 2025. This firm fixed-price, non-set-aside delivery order is being fulfilled from AmerisourceBergen's place of performance in Conshohocken, Pennsylvania. The delivery order represents a child contract issued under a larger vehicle, specifically the DLA Troop Support Medical Indefinite Delivery...
- AmerisourceBergen Drug Corp received a delivery order valued at $21,806.25 from the Defense Logistics Agency for 40 mg vials of TIVDAK, awarded on July 28, 2025, with an ultimate completion date of August 18, 2025. The contract is a firm fixed-price delivery order with no set-aside designation, competitively awarded under open procurement procedures. The place of performance is AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order is a child contract...
- The Defense Logistics Agency Medical Supply Chain awarded a $31,343.79 delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for pharmaceutical and medical supply products. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement and is scheduled for completion by July 29, 2025, with performance taking place at the vendor's Conshohocken, Pennsylvania facility. As a major pharmaceutical distributor serving federal medical procurement needs,...